Healthcare Sector Summary: Alexza Pharmaceuticals (NASDAQ:ALXA), Metabolix (NASDAQ:MBLX) – ALXA, MBLX, SHLM, CADX, PGNX, RPRX

Investors reacted positively to the healthcare stocks on Tuesday. Major movement were observed in Cadence Pharmaceuticals, Inc (NASDAQ:CADX) and Progenics Pharmaceuticals, Inc (NASDAQ:PGNX) on percentage gainers side while Repros Therapeutics Inc (NASDAQ:RPRX) was prominent stock on the losers side.

Alexza Pharmaceuticals, Inc (NASDAQ:ALXA) announced fiscal Q4 net loss was $10.27 million or $0.65 a share on Tuesday, wider than $9.69 million or $1.34 a share in previous year.

Quarterly revenues were $729 thousand, contrasted against $1.88 million in previous year.

Alexza Pharmaceuticals, Inc.’s YTD performance was recorded as -12.32% while its market capitalization was $68.09 million. The company has P/B ratio of 6.68. Institutional ownership owns 48.80% shares of the company while beta factor, which is used to measure riskiness of the security, was 1.72. Net profit margin of the company was -524.36%.

Metabolix, Inc (NASDAQ:MBLX) also on Tuesday announced fiscal Q4 net loss was $9.4 million, evaluated against a net loss of $9.6 million.

Quarterly loss on per share basis remained flat from previous year at $0.28. Total quarterly revenue was $1.4 million, evaluated against $0.4 million in previous year.

Thomson Reuters’ analysts survey most recently forecasted a loss of $0.26 per share on $1.23 million of revenues.

Metabolix, Inc. has market capitalization of $71.70 billion. Its current ratio was 10.90 while its shares were looking forward SMA50 with 8.11. The company offered earnings per share of 0.10 while its 34.31 million shares were outstanding. YTD performance of the stock was 41.22%.

A. Schulman Inc (NASDAQ:SHLM) has the market capitalization of $946.83 billion. The company’s EPS was 1.66 while its 29.33 million shares were outstanding. Its institutional ownership was 88.29%. Shares of the company were moving ahead of SMA50 with +1.33% while its YTD performance was 11.54%.

DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with! CLICK HERE TO START YOUR FREE 30-DAY TRIAL

This entry was posted in Healthcare, Latest Headlines and tagged , , , , , , , , , , , , , , , , , . Bookmark the permalink.